Candela Peña revealed she used Ozempic to achieve the physical appearance required for her role in ‘La desconocida’. The actress combined the medication with intense training. Her admission highlights a growing trend among public figures.
Candela Peña, one of Spain’s most acclaimed actresses, has openly acknowledged using Ozempic to achieve the strikingly thin and worn appearance demanded by her role in the Netflix thriller ‘La desconocida’. The revelation, made during an interview with Fotogramas, sheds light on the lengths to which actors sometimes go to meet the physical expectations of challenging characters.
Peña explained that, despite rigorous physical training and the support of a personal coach, she was unable to reach the required physique through diet alone. She turned to Ozempic, a medication originally developed for diabetes but now widely known for its weight loss effects, to help her embody the devastated woman at the center of the film. The actress noted that age played a role in her decision, as achieving such a transformation became increasingly difficult with traditional methods.
Her co-stars, Ana Rujas and Pol López, also underwent demanding physical preparation for their roles. According to Peña, Rujas faced the additional challenge of portraying a character suffering from memory loss, while both actors were required to adapt their bodies to fit the intense narrative of the film. ‘La desconocida’ has quickly become one of the most-watched thrillers on Netflix in recent weeks, drawing attention for both its storyline and the dramatic transformations of its cast.
The film follows Anna Ripoll, a detective investigating the murder of a woman whose body is discovered in a Barcelona port container. Peña’s physical change has been a focal point in discussions about the film, highlighting the increasing visibility of pharmaceutical aids like Ozempic in the entertainment industry. While Peña has not indicated whether she will continue using the medication, her openness reflects a broader shift, as more public figures begin to discuss their use of such treatments.
Ozempic, known generically as semaglutide, was initially approved for the treatment of type 2 diabetes but has gained popularity for its appetite-suppressing properties. In recent years, it has become a subject of public debate, especially as celebrities such as Oprah Winfrey and Jedet have admitted to using it for weight management. The trend has sparked conversations about body image, health risks, and the pressures faced by those in the public eye. In Spain, the use of Ozempic outside its original medical indication has raised questions about access, regulation, and the influence of celebrity culture on health decisions. As the discussion continues, Peña’s case adds a new dimension to the ongoing debate over the intersection of medicine, media, and personal transformation.
‘ The preceding article may include information circulated by third parties ’
‘ Some details of this article were extracted from the following source russpain.com ’
